Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05522491
Status:
UNKNOWN
Last Update Posted:
2022-08-31
First Post:
2022-08-28
Brief Title:
Olaparib in the Treatment of BRCA12 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-28
First Submit QC Date:
August 28 2022
Study First Post Date:
2022-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-28
Last Update Post Date:
2022-08-31
Last Update Post Date Type:
ACTUAL